Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (14 ops.)
Latest filing published 17 Nov 2014 for Edwards Lifesciences Corp, €64k.
Insider track record
Disclosed buys
1
Disclosed sells
14
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Michael R. Bowlin: trading record in brief
Michael R. Bowlin has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Edwards Lifesciences Corp, FMC Technologies Inc and Horizon Health Corp /DE/. We count 58 filings; the first trade dates from 20 January 2006 and the latest from 1 May 2015.
Market trades split into 1 purchase (€194k) and 14 sales (€5.8M). Netting one side against the other leaves €5.6M of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 28 share grants and 14 option exercises.
The newest entry dates from 5 May 2015: a share grant of €223k, in FMC Technologies Inc. The clock since the last published purchase (23 January 2007) now reads 7,214 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Michael R. Bowlin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations44 total
2,860 shares@ US$27.99Common StockSEC:0001225208-14-023439:0
650 shares@ US$124.18Common StockSEC:0001225208-14-023439:1
2,342 shares0Common StockSEC:0001225208-14-012870:0
1,093 shares@ US$24.42Common StockSEC:0001225208-14-009012:0
1,093 shares@ US$72.33Common StockSEC:0001225208-14-009012:1
1,093 shares@ US$24.42Common StockSEC:0001225208-14-006376:0
1,093 shares@ US$68.21Common StockSEC:0001225208-14-006376:1
1,092 shares@ US$24.42Common StockSEC:0001225208-14-002527:0
1,092 shares@ US$68.65Common StockSEC:0001225208-14-002527:1
2,811 shares0Common StockSEC:0001225208-13-012684:0
1,116 shares@ US$53.76Common StockSEC:0001225208-13-011168:1
3,520 shares@ US$22.72Common StockSEC:0001225208-13-005782:0
3,520 shares@ US$87.09Common StockSEC:0001225208-13-005782:1
2,361 shares0Common StockSEC:0001225208-12-012131:0
5,283 shares@ US$47.52Common StockSEC:0001225208-12-011032:0
6,896 shares@ US$11.60Common StockSEC:0001225208-12-010385:0
3,718 shares@ US$21.51Common StockSEC:0001225208-12-010385:1
4,824 shares@ US$80.51Common StockSEC:0001225208-12-010385:2
5,790 shares@ US$82.02Common StockSEC:0001225208-12-010385:3
20,000 shares@ US$12.89Common StockSEC:0001225208-12-010131:0
20,000 shares@ US$73.43Common StockSEC:0001225208-12-010131:1
2,266 shares0Common StockSEC:0001225208-11-014618:0
454 shares0Common StockSEC:0001225208-11-014618:1
17,000 shares@ US$43.73Common StockSEC:0001225208-11-013183:1
40,000 shares@ US$43.72Common StockSEC:0001225208-11-013183:2
25 of 44 declarations
